These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2862828)

  • 1. Further studies on the specificity of proglumide as a selective cholecystokinin antagonist in the central nervous system.
    Bunney BS; Chiodo LA; Freeman AS
    Ann N Y Acad Sci; 1985; 448():345-51. PubMed ID: 2862828
    [No Abstract]   [Full Text] [Related]  

  • 2. Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system.
    Chiodo LA; Bunney BS
    Science; 1983 Mar; 219(4591):1449-51. PubMed ID: 6828873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin facilitates ejaculation in male rats: blockade with proglumide and apomorphine.
    Pfaus JG; Phillips AG
    Eur J Pharmacol; 1987 Sep; 141(3):331-8. PubMed ID: 3666030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide.
    Chiodo LA; Freeman AS; Bunney BS
    Brain Res; 1987 May; 410(2):205-11. PubMed ID: 3036308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity.
    Rasmussen K; Stockton ME; Czachura JF; Howbert JJ
    Eur J Pharmacol; 1991 Dec; 209(1-2):135-8. PubMed ID: 1687681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proglumide antagonizes the stimulation of rabbit gallbladder by cholecystokinin.
    Kaplita PV; Roebuck BD
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):271-6. PubMed ID: 6476983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of cholecystokinin and dopamine in the nucleus accumbens.
    Wang RY; White FJ; Voigt MM
    Ann N Y Acad Sci; 1985; 448():352-60. PubMed ID: 2862829
    [No Abstract]   [Full Text] [Related]  

  • 8. The cholecystokinin antagonist, proglumide, increases food intake in the rat.
    Shillabeer G; Davison JS
    Regul Pept; 1984 Apr; 8(3):171-6. PubMed ID: 6463283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.
    Price DD; von der Gruen A; Miller J; Rafii A; Price C
    Anesth Analg; 1985 Aug; 64(8):801-6. PubMed ID: 4014744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholecystokinin antagonist (proglumide) potentiates the inhibitory effect of morphine on micturition reflex].
    Hisamitsu T; Okada M
    Masui; 1987 Jun; 36(6):852-6. PubMed ID: 3656653
    [No Abstract]   [Full Text] [Related]  

  • 11. Does the cholecystokinin antagonist proglumide possess antipsychotic activity?
    Innis RB; Bunney BS; Charney DS; Price LH; Glazer WM; Sternberg DE; Rubin AL; Heninger GR
    Psychiatry Res; 1986 May; 18(1):1-7. PubMed ID: 3737785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.
    Watkins LR; Kinscheck IB; Mayer DJ
    Brain Res; 1985 Feb; 327(1-2):169-80. PubMed ID: 3838690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats.
    Shillabeer G; Davison JS
    Am J Physiol; 1987 Feb; 252(2 Pt 2):R353-60. PubMed ID: 3812772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of dark-induced hyperlocomotion by a cholecystokinin antagonist in the nucleus accumbens.
    Crawley JN
    Brain Res; 1988 Nov; 473(2):398-400. PubMed ID: 3233498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo comparison of inhibition with proglumide and CR-1409 of cholecystokinin-induced pressure in the biliary tract of the guinea pig.
    Poston GJ; MacLellan DG; Hashimoto T; Upp JR; Townsend CM; Thompson JC
    Surg Gynecol Obstet; 1990 Mar; 170(3):217-22. PubMed ID: 2305348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide.
    Watkins LR; Kinscheck IB; Mayer DJ
    Science; 1984 Apr; 224(4647):395-6. PubMed ID: 6546809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proglumide inhibits cholecystokinin and meal-stimulated pancreatic secretion and release of pancreatic polypeptide.
    Beauchamp RD; Gomez G; Nealon WH; Townsend CM; Greeley GH; Thompson JC
    Surgery; 1990 Sep; 108(3):553-8. PubMed ID: 2396199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of proglumide on rat pancreatic growth.
    Yamaguchi T; Tabata K; Johnson LR
    Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proglumide prevents and curtails acute tolerance to morphine in rats.
    Tang J; Chou J; Iadarola M; Yang HY; Costa E
    Neuropharmacology; 1984 Jun; 23(6):715-8. PubMed ID: 6462377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cholecystokinin and of its antagonist, of atropine, and of food on the release of immunoglobulin A and immunoglobulin G specific antibodies in the rat intestine.
    Freier S; Eran M; Faber J
    Gastroenterology; 1987 Dec; 93(6):1242-6. PubMed ID: 3678742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.